These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7247232)

  • 1. [Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].
    Choay J; Lormeau JC; Petitou M
    Ann Pharm Fr; 1981 May; 39(1):37-44. PubMed ID: 7247232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low molecular weight oligosaccharides active in plasma against factor Xa. II. New structural elements and antithrombotic activity (author's transl)].
    Choay J; Lormeau JC; Petitou M; Fareed J; Sinaÿ P
    Ann Pharm Fr; 1981 Jul; 39(3):267-72. PubMed ID: 7294654
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synthesis of N-alpha-(arylsulfonylglycyl)-3-amidinophenylalanine esters as active and relatively specific inhibitors of factor Xa].
    Vieweg H; Wagner G
    Pharmazie; 1987 Apr; 42(4):268. PubMed ID: 3615560
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic irreversible inhibitors of coagulation enzymes.
    Shaw E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):33-42. PubMed ID: 6177606
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulants with antithrombinase activity in systemic lupus erythematosus (author's transl)].
    Jungers P; Dougados M; Ganzegel C; Kremp O; Jacques C; Noel LH; Josso F
    Nephrologie; 1980; 1(2):67-8. PubMed ID: 7301023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural studies on a biologically active hexasaccharide obtained from heparin.
    Choay J; Lormeau JC; Petitou M; Sinaÿ P; Fareed J
    Ann N Y Acad Sci; 1981; 370():644-9. PubMed ID: 6943974
    [No Abstract]   [Full Text] [Related]  

  • 7. Immobilization of high-affinity heparin oligosaccharides to radiofrequency plasma-modified polyethylene.
    Yuan S; Szakalas-Gratzl G; Ziats NP; Jacobsen DW; Kottke-Marchant K; Marchant RE
    J Biomed Mater Res; 1993 Jun; 27(6):811-9. PubMed ID: 8408111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macroglobulin activated factor X inhibitor in human plasma (author's transl)].
    Imaoka S
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):579-83. PubMed ID: 567923
    [No Abstract]   [Full Text] [Related]  

  • 12. [New antithrombotic oligosaccharides].
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel inhibitor of factor X activation from the salivary glands of the bed bug Cimex lectularius.
    Valenzuela JG; Guimaraes JA; Ribeiro JM
    Exp Parasitol; 1996 Jul; 83(2):184-90. PubMed ID: 8682187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins.
    Young E; Cosmi B; Weitz J; Hirsh J
    Thromb Haemost; 1993 Oct; 70(4):625-30. PubMed ID: 8115988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the synthetic pentasaccharide SR 90107/ORG 31540 on thrombin generation ex vivo is uniquely due to ATIII-mediated neutralization of factor Xa.
    Lormeau JC; Herault JP
    Thromb Haemost; 1995 Dec; 74(6):1474-7. PubMed ID: 8772223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-factor Xa plasma activity in patients receiving coumarin derivatives therapy (author's transl)].
    Recalcati P; Pogliani E
    Haematologica; 1976 Mar; 61(1):20-34. PubMed ID: 820595
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterisation of persistent anti-Xa activity following administration of the low molecular weight heparin enoxaparin sodium (Clexane).
    Brieger D; Dawes J
    Thromb Haemost; 1994 Aug; 72(2):275-80. PubMed ID: 7831665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.